860692P

C16:0 Ceramide (d18:2(4E,8Z)/16:0)

Avanti Research^™ - A Croda Brand 860692P, powder

• Synonym(e): N-palmitoyl-D-erythro-sphingosine (d18:2(4E,8Z) base)
• Empirische Formel (Hill-System): C₃₄H₆₅NO₃
• CAS-Nummer: 1919028-96-8
• Molekulargewicht: 535.88
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: powder
• Verpackung: pkg of 1 × 1 mg (860692P-1mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 860692P
• Lipid-Typ: sphingolipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: OC[C@@](NC(CCCCCCCCCCCCCCC)=O)([H])[C@]([H])(O)/C=C/CC/C=C\CCCCCCCCC

Beschreibung

Allgemeine Beschreibung

C16:0 Ceramide (d18:2(4E,8Z)/16:0) or N-palmitoyl-D-erythro-sphingosine (d18:2(4E,8Z) base) is a long chain ceramide derived from sphingosine containing two double bonds with palmitic acid. C16:0 Ceramide synthesis is catalyzed by the enzyme ceramide synthase 6 (CerS6).

Biochem./physiol. Wirkung

C16:0-ceramide facilitates obesity-related insulin resistance. It exhibits pro-apoptotic function. Elevated levels of C16:0-ceramide has been observed in adipose tissue of obese patients.

Verpackung

5 mL Amber Glass Screw Cap Vial (860692P-1mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): No data available
• Flammpunkt (°C): No data available